The proton oligopeptide cotransporter family SLC15 in physiology and pharmacology
about
The Role of Cyclo(His-Pro) in NeurodegenerationMolecular insights into proton coupled peptide transport in the PTR family of oligopeptide transportersThe role of drug transporters in the kidney: lessons from tenofovirIntracellular nucleic acid sensors and autoimmunityStrategies of bacterial over expression of membrane transporters relevant in human health: the successful case of the three members of OCTN subfamilyThe intestinal peptide transporter PEPT1 is involved in food intake regulation in mice fed a high-protein dietCrystal structure of a prokaryotic homologue of the mammalian oligopeptide-proton symporters, PepT1 and PepT2Alternating access mechanism in the POT family of oligopeptide transportersTransporters at CNS barrier sites: obstacles or opportunities for drug delivery?Physiology and pathophysiology of carnosine.Substrate preference is altered by mutations in the fifth transmembrane domain of Ptr2p, the di/tri-peptide transporter of Saccharomyces cerevisiae.Blood brain barrier: a challenge for effectual therapy of brain tumorsAnti-aggregating effect of the naturally occurring dipeptide carnosine on aβ1-42 fibril formationThe Concise Guide to PHARMACOLOGY 2013/14: transporters.High-affinity peptide transporter PEPT2 (SLC15A2) of the zebrafish Danio rerio: functional properties, genomic organization, and expression analysis.From bacteria to man: archaic proton-dependent peptide transporters at work.Synthesis and characterization of a new and radiolabeled high-affinity substrate for H+/peptide cotransporters.Molecular cloning and functional expression of atlantic salmon peptide transporter 1 in Xenopus oocytes reveals efficient intestinal uptake of lysine-containing and other bioactive di- and tripeptides in teleost fish.Gene ablation for PEPT1 in mice abolishes the effects of dipeptides on small intestinal fluid absorption, short-circuit current, and intracellular pH.H+-coupled nutrient, micronutrient and drug transporters in the mammalian small intestineThe identification of novel proteins that interact with the GLP-1 receptor and restrain its activityXenobiotic, bile acid, and cholesterol transporters: function and regulation.Amino acid absorption and homeostasis in mice lacking the intestinal peptide transporter PEPT1.Genome-wide screening of DNA methylation associated with lymph node metastasis in esophageal squamous cell carcinoma.Enhanced antinociceptive response to intracerebroventricular kyotorphin in Pept2 null miceTransport mechanisms of carnosine in SKPT cells: contribution of apical and basolateral membrane transporters.PepT1 mediates transport of the proinflammatory bacterial tripeptide L-Ala-{gamma}-D-Glu-meso-DAP in intestinal epithelial cells.Significance and regional dependency of peptide transporter (PEPT) 1 in the intestinal permeability of glycylsarcosine: in situ single-pass perfusion studies in wild-type and Pept1 knockout miceExpression profile and functional activity of peptide transporters in prostate cancer cells.Divergent developmental expression and function of the proton-coupled oligopeptide transporters PepT2 and PhT1 in regional brain slices of mouse and ratEvolutionary classification of ammonium, nitrate, and peptide transporters in land plants.Functional properties of the Arabidopsis peptide transporters AtPTR1 and AtPTR5Peptide transporter 1 is responsible for intestinal uptake of the dipeptide glycylsarcosine: studies in everted jejunal rings from wild-type and Pept1 null miceDisposition kinetics of a dipeptide ester prodrug of acyclovir and its metabolites following intravenous and oral administrations in rat.The peptide transporter PEPT1 is expressed in distal colon in rodents and humans and contributes to water absorption.Thermodynamic evidence for a dual transport mechanism in a POT peptide transporterAnalysing the substrate multispecificity of a proton-coupled oligopeptide transporter using a dipeptide library.Peptide transporter DtpA has two alternate conformations, one of which is promoted by inhibitor binding.L-Ala-γ-D-Glu-meso-diaminopimelic acid (DAP) interacts directly with leucine-rich region domain of nucleotide-binding oligomerization domain 1, increasing phosphorylation activity of receptor-interacting serine/threonine-protein kinase 2 and its intEffect of dose escalation on the in vivo oral absorption and disposition of glycylsarcosine in wild-type and Pept1 knockout mice.
P2860
Q26741190-47646C28-418E-457D-A3B4-A09F7894C10FQ26830326-A262C15A-F171-4388-A0F1-1133FD9CF5A0Q26866489-2DF883E3-33A2-4341-BAAD-CD7440D194ACQ26997316-189D5C52-7A2C-4D89-A084-1FD1CFCAF641Q27010565-1CE154DF-B917-4021-A3CB-7834742FBBB1Q27316173-AE95AAB7-F904-4BEE-B000-500A0F601939Q27666182-040CB9B7-3D2E-433F-8745-1440047F7C93Q27679456-C4B77601-F4BE-43DD-AD40-CB71269DD818Q27690256-AE1335B9-745F-4DE5-80EF-1535D184DB63Q27692648-B0E83E3B-016A-41D2-A43D-68DBFED8D46AQ27930126-C64B7BF7-803E-40AE-A954-ED85D14DF81AQ28081947-A60AC938-9312-4342-9D78-500BC0B2E5CBQ28534489-824FECAE-1B1E-42D1-BA93-F929421B1EE5Q30486743-7CC1CD1F-D32E-4FE3-82C7-AF06EB0E474EQ33228147-2D026B5F-581D-47D9-B13D-DA5F0D3756E7Q33237678-E6B960A7-AA74-4287-AF8C-DD85C4F2B55EQ33303049-B7AC1A09-2EC6-4E6A-BF51-1F71D7DDBA92Q33539523-2EC1699A-18B6-4E5C-AA4D-8BE2C3BBFD16Q33568372-AD077B8C-8090-416F-B125-9D9677CBF9E6Q33578118-C4983216-DF76-4D47-9D6D-8CCA29B74EEDQ33633076-C3AB7064-C657-4BCE-8857-9D593D95011DQ33714593-E7A03190-4131-4253-B92F-EB811586855EQ33829554-0A33CBE5-EB95-4434-8E58-3AD809737FC1Q33914119-64905A95-7D98-4A8C-8B35-EB3D26AACE99Q33967939-C0139E00-AA2A-44EC-8EAA-9631FD989FC3Q34033173-0C8FA42D-BA91-4783-9AD5-F477D61025B9Q34178926-F70F6099-6A57-47B8-8397-3AF64E1ACEA8Q34211071-36D8F153-F2BE-450B-B712-023EB2D5FC65Q34267875-5E13B40C-7C4A-4FF5-AA36-56ADD60FEF94Q34273987-0EB0EFE0-DC56-4EEB-86EE-ED58215B8C74Q34398611-56767A0B-75DF-49E5-AA3E-CA9F54FE6807Q34400817-69128C7C-69C7-4C22-8BDB-E5AED57AA762Q34442058-6A1DF69D-7E13-476C-9D42-BC8164911949Q34530168-69C5349B-F164-465F-9F5C-7BC1A54BAC70Q34713943-72D4E044-6416-4CE5-9D5E-067F6C3BD959Q34737607-238FA781-E465-4A66-9761-5CBF5A02240DQ34995844-2BEF9A55-E191-4309-AE4D-ADE1941DDBA9Q35003135-9ED27B8C-C82C-448A-8794-CBA263E65E15Q35183042-4BA350D1-0237-4B8F-A7BD-E371C021D203Q35579541-D91B7E00-1683-4900-BC4A-A8191121300A
P2860
The proton oligopeptide cotransporter family SLC15 in physiology and pharmacology
description
2004 nî lūn-bûn
@nan
2004 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
The proton oligopeptide cotransporter family SLC15 in physiology and pharmacology
@ast
The proton oligopeptide cotransporter family SLC15 in physiology and pharmacology
@en
The proton oligopeptide cotransporter family SLC15 in physiology and pharmacology
@nl
type
label
The proton oligopeptide cotransporter family SLC15 in physiology and pharmacology
@ast
The proton oligopeptide cotransporter family SLC15 in physiology and pharmacology
@en
The proton oligopeptide cotransporter family SLC15 in physiology and pharmacology
@nl
prefLabel
The proton oligopeptide cotransporter family SLC15 in physiology and pharmacology
@ast
The proton oligopeptide cotransporter family SLC15 in physiology and pharmacology
@en
The proton oligopeptide cotransporter family SLC15 in physiology and pharmacology
@nl
P3181
P1433
P1476
The proton oligopeptide cotransporter family SLC15 in physiology and pharmacology
@en
P2888
P3181
P356
10.1007/S00424-003-1101-4
P407
P577
2004-02-01T00:00:00Z
P6179
1052707649